Launch of the first evaluation phase of the application in Amman (Jordan)
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
In Amman (Jordan), the ASTapp team has launched the first evaluation phase of the application. Following this, the second evaluation phase will start in February 2020, also in Amman. Finally, the third and last phase will take place between June and November 2020 and will be divided between three countries : Jordan, Mali and the Central African Republic.
The rapid diagnostic test (RDT) for measles produced by DIATROPIX, the manufacturing platform of the Pasteur Institute in Dakar, has reached a new milestone.The MSF Foundation has been su...
The Optimilk F-60 project has reached a key milestone: the first children have been enrolled in the Phase 1 clinical trial evaluating the safety and tolerability of F-60, a new therapeuti...
